News By Tag
News By Location
Follow on Google News
Global IVD Contract Manufacturing Services Market set to reach $5.6 Billion by 2026
In-vitro diagnostics (IVD) are tests done on samples such as blood or tissue to detect diseases or other conditions. It is used to keep track of a person's overall health to help cure, treat, or prevent diseases.
Rising Preference for Point-of-Care (POC) Testing Services Fuels the IVD Contract Manufacturing Services Market
In an endeavor to cut result time and support patients make better-informed decisions about their health, there is considerable demand for IVD testing to move closer to the patient i.e., point-of-care (POC) diagnostics whether in the hospital, clinic, physician's office, or home.
Manufacturing of specific PoC devices presents manufacturers (OEMs) with a variety of design and manufacturing challenges. For instance, the ability to process high-precision components that involve reagents and fluids are the most relevant capabilities sought by OEMs, which are accomplished by specialized IVD CDMOs.
IVD Diagnostic Kits Demand Triggered by Covid-19 Bolsters the IVD Contract Manufacturing Services Market
The need for IVDs has risen since the Covid-19 outbreak, which in turn has fueled the demand for IVD Contract Manufacturing Services. There are several types of SARS-CoV-2 and COVID-19 related IVDs - diagnostic tests, serology/antibody and other adaptive immune response tests and tests for management of COVID-19 patients.
Explore Premium Report on IVD Contract Manufacturing Services Market @ https://meditechinsights.com/
Competitive Landscape Analysis of IVD Contract Manufacturing Services Market
The global IVD contract manufacturing services market is marked by the presence of key players such as Jabil, STRATEC, Celestica, Sanmina Gerresheimer, Phillips-Medisize, Plexus, Röchling, KMC Systems, Cenogenics Corporation, Savyon Diagnostics, Nova Biomedical, Cone Bioproducts, Invetech, Inc., Thermo Fisher Scientific Inc., Avioq, Inc., LRE Medical, Coris BioConcept, Meridian Bioscience, Inc., Maxim Biomedical, Inc., among others.
+ 32 498 86 80 79